Application of 31P MR Spectroscopy to the Brain Tumors

Objective To evaluate the clinical feasibility and obtain useful parameters of 31P magnetic resonance spectroscopy (MRS) study for making the differential diagnosis of brain tumors. Materials and Methods Twenty-eight patients with brain tumorous lesions (22 cases of brain tumor and 6 cases of abscess) and 11 normal volunteers were included. The patients were classified into the astrocytoma group, lymphoma group, metastasis group and the abscess group. We obtained the intracellular pH and the metabolite ratios of phosphomonoesters/phosophodiesters (PME/PDE), PME/inorganic phosphate (Pi), PDE/Pi, PME/adenosine triphosphate (ATP), PDE/ATP, PME/phosphocreatine (PCr), PDE/PCr, PCr/ATP, PCr/Pi, and ATP/Pi, and evaluated the statistical significances. Results The brain tumors had a tendency of alkalization (pH = 7.28 ± 0.27, p = 0.090), especially the pH of the lymphoma was significantly increased (pH = 7.45 ± 0.32, p = 0.013). The brain tumor group showed increased PME/PDE ratio compared with that in the normal control group (p = 0.012). The ratios of PME/PDE, PDE/Pi, PME/PCr and PDE/PCr showed statistically significant differences between each brain lesion groups (p < 0.05). The astrocytoma showed an increased PME/PDE and PME/PCr ratio. The ratios of PDE/Pi, PME/PCr, and PDE/PCr in lymphoma group were lower than those in the control group and astrocytoma group. The metastasis group showed an increased PME/PDE ratio, compared with that in the normal control group. Conclusion We have obtained the clinically applicable 31P MRS, and the pH, PME/PDE, PDE/Pi, PME/PCr, and PDE/PCr ratios are helpful for differentiating among the different types of brain tumors.

[1]  T. Ng,et al.  Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. , 1989, Radiology.

[2]  Gregory S Karczmar,et al.  MRI of the tumor microenvironment , 2002, Journal of magnetic resonance imaging : JMRI.

[3]  G B Matson,et al.  P-31 MR spectroscopy of normal human brain and brain tumors. , 1990, Radiology.

[4]  J. Griffiths Are cancer cells acidic? , 1991, British Journal of Cancer.

[5]  Walter Heindel,et al.  Phosphorus‐31 MR spectroscopy of normal adult human brain and brain tumours , 2002, NMR in biomedicine.

[6]  W. Heiss,et al.  Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[7]  Marvin D Nelson,et al.  Proton‐decoupled 31P MRS in untreated pediatric brain tumors , 2005, Magnetic resonance in medicine.

[8]  D. Collins,et al.  A quantitative analysis of the accuracy of In Vivo pH measurements with 31P NMR spectroscopy: Assessment of pH measurement methodology , 1991, NMR in biomedicine.

[9]  W. Negendank,et al.  Studies of human tumors by MRS: A review , 1992, NMR in biomedicine.

[10]  Filip Jiru,et al.  Spectroscopic imaging: basic principles. , 2008, European journal of radiology.

[11]  Ewald Moser,et al.  Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review , 2007, NMR in biomedicine.

[12]  K. Hossmann,et al.  Regional metabolism in experimental brain tumors in cats: relationship with acid/base, water, and electrolyte homeostasis. , 1992, Journal of Neurosurgery.

[13]  Peter M. Rothwell,et al.  Normal Cortical Energy Metabolism in Migrainous Stroke: A 31P-MR Spectroscopy Study , 2009, Stroke.

[14]  C. Tanaka,et al.  Pathophysiological investigation of experimental cerebral ischaemia using in vivo 31P-NMR spectroscopy and 1H-MRI. , 1988, Acta neurochirurgica. Supplementum.

[15]  C. Herzog,et al.  Cardiac (31)P-MRS compared to echocardiographic findings in patients with hypertensive heart disease without overt systolic dysfunction--preliminary results. , 2009, European journal of radiology.

[16]  B. Gusterson,et al.  Monitoring tumor growth and regression by 31P magnetic resonance spectroscopy. , 1990, Advances in enzyme regulation.

[17]  A. Aisen,et al.  MR spectroscopy: clinical perspective. , 1989, Radiology.

[18]  M. Neeman,et al.  Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy. , 1989, Cancer research.

[19]  S F Keevil,et al.  The performance of volume selection sequences for in vivo NMR spectroscopy: implications for quantitative MRS. , 2001, Magnetic resonance imaging.

[20]  C. Tanaka,et al.  The investigation of experimental brain tumours using 31P-MRS and 1H-MRI. , 1988, Acta neurochirurgica. Supplementum.

[21]  J. Park,et al.  Human in-vivo 31P MR Spectroscopy of Benign and Malignant Breast Tumors , 2001, Korean journal of radiology.

[22]  J. Glickson,et al.  Inhibition of Tumor Cell Proliferation by Dexamethasone: 31P NMR Studies of RIF‐1 Fibrosarcoma Cells Perfused In Vitro , 1996, NMR in biomedicine.

[23]  D. Hoffmann,et al.  MR spectroscopy of bilateral thalamic gliomas. , 1999, AJNR. American journal of neuroradiology.

[24]  F. Podo Tumour phospholipid metabolism , 1999, NMR in biomedicine.

[25]  G. Radda,et al.  The study of human organs by phosphorus-31 topical magnetic resonance spectroscopy. , 1987, The British journal of radiology.

[26]  M. Pisanu,et al.  MR evaluation of response to targeted treatment in cancer cells , 2011, NMR in biomedicine.

[27]  J. Cohen Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance. , 1988, Mayo Clinic proceedings.

[28]  M. Hoehn,et al.  1H‐ and 31P‐MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy‐characteristic profiles of water soluble and lipophilic spectral components , 2001, NMR in biomedicine.

[29]  T. Brown,et al.  In vivo 31P MR spectral patterns and reproducibility in cancer patients studied in a multi‐institutional trial , 2006, NMR in biomedicine.

[30]  E. Shoubridge,et al.  Characterization of astrocytomas, meningiomas, and pituitary adenomas by phosphorus magnetic resonance spectroscopy. , 1991, Journal of neurosurgery.